Magnera Corp
Magnera supplies specialty materials made from organic and synthetic raw ingredients for disposable and durable products. Its customers include global and national brands, private-label businesses, and small to mid-sized regional companies. Products serve end markets including wipes, healthcare, apparel, baby and feminine care, filtration, and food and beverage; Magnera also provides technical solutions for infrastructure markets. It sells through a direct sales force. Magnera operates two segments, Americas and Rest of World. The segments manufacture personal care and consumer products and components, including medical garments, wipes, dryer sheets, tea bags, coffee filters, cable wrap, filtration products, diapers, and adult incontinence products. Magnera has 22 manufacturing facilities in the Americas and 23 in the Rest of World segment. Its primary raw materials are polymer resin, wood-based fibers, and pulps. Magnera is headquartered in Charlotte, North Carolina.
No enriched coverage for $MAGN in the last 7 days.
No SEC Form 4 filings for $MAGN in the last 30 days.
See all $MAGN insider activity →Magnera Corporation (NYSE:MAGN) has partnered with the U.S. Army to evaluate its OmniSep battery separator technology for defense, infrastructure, and commercial uses. The collaboration aims to enhance battery performance, safety, and reliability. Magnera's CEO highlighted the potential impact across various markets. The company operates globally with 44 facilities and 8,000 employees.
Magnera Corporation (MAGN) has commissioned a new five-layer film production line in Germany, with commercial production expected to start in October 2026. The expansion aims to increase capacity for lightweight and elastic films, supporting the company's growth and innovation goals.
Magnera (MAGN) reported Q3 FY2026 net sales of $857 million, up 2% from $839 million, with organic volume growth of 1%. Non-GAAP adjusted EBITDA rose to $99 million. Full-year free cash flow guidance is $90 million to $110 million, and liquidity was $575 million. Total debt was $1.9 billion. Risks cited include faster raw-material inflation and weaker Europe demand.
Recent MAGN coverage spans earnings, financial news and technology.
The Army partnership validates Magnera's technology and may open defense and infrastructure markets.
The new line adds lightweight film capacity, potentially boosting revenue once online.
Guidance mix is supportive on cash flow but flags margin pressure from accelerated raw material inflation and Rest of World price timing lags.
Guidance skew to lower adjusted EBITDA despite stable FCF outlook suggests margin pressure and cost recovery lag, likely weighing on near-term sentiment.
Magnera Corp. reported its strongest Q3 2026 earnings quarter since the merger, citing Project CORE run-rate realization and merger synergies. It maintained stable earnings, grew organic sales 1%, and reaffirmed full-year free cash flow guidance of $90M to $110M. Magnera lowered EBITDA expectations, cut CapEx to about $60M, and expects $20M of incremental synergies in FY2027.
AlphAI scores every news story that mentions MAGN with an AI model for sentiment and relevance, and aggregates insider trades from Magnera Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Magnera Corporation (NYSE:MAGN) has partnered with the U.S. Army to evaluate its OmniSep battery separator technology for defense, infrastructure, and commercial uses. The collaboration aims to enhance battery performance, safety, and reliability. Magnera's CEO highlighted the potential impact across various markets. The company operates globally with 44 facilities and 8,000 employees.
Magnera Corporation (MAGN) has commissioned a new five-layer film production line in Germany, with commercial production expected to start in October 2026. The expansion aims to increase capacity for lightweight and elastic films, supporting the company's growth and innovation goals.
Magnera (MAGN) reported Q3 FY2026 net sales of $857 million, up 2% from $839 million, with organic volume growth of 1%. Non-GAAP adjusted EBITDA rose to $99 million. Full-year free cash flow guidance is $90 million to $110 million, and liquidity was $575 million. Total debt was $1.9 billion. Risks cited include faster raw-material inflation and weaker Europe demand.
Magnera (NYSE:MAGN) reported Q3 updates on infrastructure and filtration-related sales, with Americas revenue essentially flat year over year. Adjusted EBITDA rose 16% to $71 million in the Americas. The company reaffirmed full-year free cash flow of about $90M to $110M, but expects full-year adjusted EBITDA toward the low end of its prior range, citing inflation and macro uncertainty.
Magnera Corp. reported its strongest Q3 2026 earnings quarter since the merger, citing Project CORE run-rate realization and merger synergies. It maintained stable earnings, grew organic sales 1%, and reaffirmed full-year free cash flow guidance of $90M to $110M. Magnera lowered EBITDA expectations, cut CapEx to about $60M, and expects $20M of incremental synergies in FY2027.
Magnera Corp (MAGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Magnera Reports Third Quarter Third Quarter Highlights • GAAP: Net sales of $857 million, Operating income of $22 million • Non-GAAP: Adjusted EBITDA of $99 million • Twelve-month adjusted free cash flow yield of greater than 25% as of quarter-end Curt B
Magnera Corp. (NYSE: MAGN) said it has agreed to sell its Caerphilly, UK operations to Polyart Group, owned by Prudentia Capital. Magnera initiated a strategic review of its manufacturing technologies and markets, leading to a sale process for its metallized paper business. Polyart will buy 100% of the Caerphilly shares.
Magnera (NYSE: MAGN) introduced Universa™, a consolidated industrial wiper line combining the Chicopee® and Sontara® brands’ technologies. The company says Universa™ uses three nonwoven platforms—Airlaid, Spinlace®, and Sontara®—to cover daily, heavy-duty, and precision cleaning, with products Universa™ Core, Plus, and Max. Chicopee® and Sontara® remain core brands; Universa™ is made in the U.S.
CHARLOTTE, N.C., Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Magnera Corporation ( NYSE:MAGN ) today announced it will participate in the 2025 Bank of America Leveraged Finance Conference.
CHARLOTTE, N.C., Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Magnera Corporation ( NYSE: MAGN ) today announced it will participate in the 2025 Bank of America Leveraged Finance Conference. Magnera CEO, Curt Begle, CFO, Jim Till, and EVP, Corporate Development, Investor Relations & Strategy, Robert ...
